266.53MMarket Cap-117000P/E (TTM)
3.665High3.310Low450.81KVolume3.310Open3.290Pre Close1.59MTurnover0.92%Turnover RatioLossP/E (Static)75.93MShares4.65052wk High8.67P/B171.18MFloat Cap1.25052wk Low--Dividend TTM48.77MShs Float23.660Historical High--Div YieldTTM10.79%Amplitude0.052Historical Low3.530Avg Price1Lot Size
ChromaDex Stock Forum
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
ChromaDex Corp. (NASDAQ:CDXC) has secured U.S. Patent number 10,000,520 C1 for the composition of matter of salt forms of NMNH (dihydronicotinamide mononucleotide), a precursor to NAD+. This patent, co-owned with Queen's University Belfast, grants ChromaDex exclusive rights to the disodium salt form of NMNH. The company now has over ...
ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
ChromaDex Corp. (NASDAQ:CDXC) announces the debut of pharmaceutical-grade Niagen® (nicotinamide riboside chloride) for intravenous and injectable use at leading wellness clinics in August. Wells Pharma of Houston, a U.S. FDA-registered 503B outsourcing facility, will compound and distribute Niagen+ to select IV clinics.
Niagen IV offers superior t...
NEWS
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
Go go CDXC! 🥳
Nice! Li kaishing very own elixir biomedical company .
$BABA-SW (09988.HK)$ $UOB (U11.SG)$ $CapLand Ascott Trust (HMN.SG)$ $Sembcorp Ind (U96.SG)$ $Yum China (YUMC.US)$ $IFAST (AIY.SG)$ $CKI FIN B2412 (05060.HK)$
$Futu Holdings Ltd (FUTU.US)$ $Ginkgo Bioworks (DNA.US)$ $Day One Biopharmaceuticals (DAWN.US)$ $Alibaba (BABA.US)$
No comment yet